載入...
The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study
Midazolam is metabolized by the developmentally regulated intestinal and hepatic drug‐metabolizing enzyme cytochrome P450 (CYP) 3A4/5. It is frequently administered orally to children, yet knowledge is lacking on the oral bioavailability in term neonates up until 1 year of age. Furthermore, the disp...
Na minha lista:
| 發表在: | Clin Pharmacol Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7818442/ https://ncbi.nlm.nih.gov/pubmed/32403162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.1890 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|